Senior Director, Emerging Science and Pipeline Marketing Community Lead

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

Senior Director, Emerging Science & Pipeline Strategy Marketing Community Lead

As the Senior Director, Emerging Science & Pipeline Strategy Marketing Community Lead, you are accountable for shaping the future HCP commercial portfolio through early commercialization strategy, customer ecosystem development, launch readiness, and transition planning across emerging assets and strategic opportunities.

Reporting to the VP, HCP Experience, you will partner closely with Therapeutic Community Leads, Indication Strategy Leads, Customer Engagement & Experience, Medical Affairs, Clinical Development, Business Development, Insights, and other enterprise partners to bring commercial and customer perspective into emerging opportunities, inform asset and development decisions, and prepare assets to transition successfully into therapeutic communities.
Roles & Responsibilities
Emerging Science & Pipeline Strategy

-
Lead HCP commercial strategy across pipeline assets, future indications, exploratory opportunities, partnerships / licensing opportunities, and other strategic opportunities.

-
Translate enterprise HCP Experience priorities into early commercialization strategies that support launch readiness, customer ecosystem development, portfolio growth, and informed investment decisions.

-
Maintain the community-level view of emerging customer needs, therapeutic landscapes, KOL networks, academic centers, referral dynamics, and other stakeholders shaping future market development.

-
Assess emerging opportunities and provide commercial perspective on relative priority, customer opportunity, readiness, resource needs, and strategic optionality.

-
Partner with asset, development, Medical Affairs, Business Development, and commercial teams to ensure customer and ecosystem insights inform asset strategy, evidence planning, launch planning, and market development.

-
Elevate emerging customer, scientific, market, and pipeline insights to senior leaders to inform prioritization and investment decisions.

Customer Ecosystem, Launch Readiness & Transition

-
Develop an integrated Emerging Science & Pipeline Strategy plan connecting customer insights, KOL strategy, launch readiness, pipeline opportunities, and cross-functional priorities.

-
Lead early customer planning, including ecosystem mapping, emerging KOL identification, academic center prioritization, and customer journey implications.

-
Shape early HCP education and engagement approaches in partnership with Medical Affairs, Clinical Development, Customer Engagement & Experience, Insights, and TLL leadership.

-
Establish launch and transition readiness criteria for movement of assets into Neurology, Rheumatology, or future therapeutic communities.

-
Lead transition planning to ensure customer ecosystem continuity, clear handoffs, resource readiness, and accountability as assets move into scaled execution.

-
Monitor scientific, market, customer, and competitive dynamics and adjust priorities and transition plans as the pipeline evolves.

Cross-Functional Leadership & Capability Building

-
Serve as a senior HCP marketing and commercialization leader across emerging science, pipeline strategy, and early commercialization.

-
Build strong